Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inter partes review
Pharma
Viatris gets US agency to review Novo semaglutide patent
After hearing a petition from Viatris, the USPTO will conduct a review to determine the validity of a patent held by Novo Nordisk on semaglutide.
Kevin Dunleavy
Oct 5, 2023 9:10am
Alexion's Soliris gets a reprieve with Amgen biosim settlement
Jun 1, 2020 11:31am
Biogen wins Tecfidera patent challenge from Mylan; shares jump
Feb 5, 2020 1:43pm
Alexion's Soliris patents on the line as PTO takes Amgen petition
Aug 30, 2019 9:42am
Gilead challenges the feds' HIV prevention patents on Truvada
Aug 22, 2019 10:42am
Bristol's Celgene quest gets a boost from Revlimid patent win
Mar 14, 2019 12:09pm
